Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Regenxbio (RGNX) over the last 11 years, with Q3 2025 value amounting to 0.36%.

  • Regenxbio's Return on Capital Employed rose 2000.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.56% for FY2024, which is 900.0% down from last year.
  • As of Q3 2025, Regenxbio's Return on Capital Employed stood at 0.36%, which was up 2000.0% from 0.4% recorded in Q2 2025.
  • Over the past 5 years, Regenxbio's Return on Capital Employed peaked at 0.19% during Q4 2021, and registered a low of 0.6% during Q4 2024.
  • For the 5-year period, Regenxbio's Return on Capital Employed averaged around 0.3%, with its median value being 0.38% (2023).
  • Per our database at Business Quant, Regenxbio's Return on Capital Employed surged by 4300bps in 2022 and then crashed by -6300bps in 2023.
  • Regenxbio's Return on Capital Employed (Quarter) stood at 0.19% in 2021, then plummeted by -287bps to 0.36% in 2022, then crashed by -57bps to 0.57% in 2023, then dropped by -6bps to 0.6% in 2024, then skyrocketed by 40bps to 0.36% in 2025.
  • Its last three reported values are 0.36% in Q3 2025, 0.4% for Q2 2025, and 0.42% during Q1 2025.